Alder BioPharmaceuticals closed a $38 million Series D round led by a new investor—Novo Ventures—and including existing Alder investors Sevin Rosen Funds, Ventures West, WRF Capital, H.I.G. Ventures, Delphi Ventures and TPG Biotech. Novo’s Peter Bisgaard will join Alder’s board as part of the deal. Alder BioPharma is based in Washington and is develops products [...]

U.S. solar start-up Suniva Inc., which is backed by a long line of brand-name investors including Warburg Pincus and New Enterprise Associates, has closed on $94.3 million of a proposed $115 million equity financing round, according to a filing with the Securities and Exchange Commission.

Venture capital-backed biotech company CardioFocus has secured $5 million in debt financing from Silicon Valley Bank. The company has raised venture funding from investors including Accuitive Medical Ventures, Aurora Funds, Kestrel Venture Management, Oxford Biosciences Partners, SV Life Sciences Advisors, HIG Ventures and KBL Healthcare Ventures. The debt financing will help it initiate its pivotal trial in the U.S. and to expand the commercialization of its products in Europe, the company said in a statement. CardioFocus is based in Massachusetts.

We’ll keep bringing you potential (and, some completed) funding opportunities from S.E.C. filings, and, please, if you’re an executive/banker/entrepreneur who knows of a potential deal for a VC, kick it our way. Today, we’ve got companies that just completed some fundraisings, as well as others that are just a hair shy, still. IN THE MARKET [...]

Boca Raton, Fla.-based LOC-AID has raised $13 million in Series C financing. H.I.G. Ventures led the round, which included participation from Intersouth Partners, and the Florida Growth Fund, which is managed by Hamilton Lane. The new money will help LOC-AID expand its technology, which includes location-based services for fraud prevention, proximity marketing, asset management and check-in services.

Florida-based H.I.G. Ventures is in the market with a new venture capital fund focused exclusively on life sciences companies. The firm had allocated around half of its $300 million second fund to life sciences investing, according to managing director Aaron Davidson, but now feels that the strategy deserves a dedicated vehicle.

The fund will focus primarily on companies developing therapeutic drugs or medical devices across sectors and stages, Davidson said. Specifically, “capital efficient businesses with large market opportunities in underserved geographies, and products with shorter development.”

H.I.G. Ventures invested in Triad Digital Media, LLC, a Tampa, FL-based online advertising services company. The deal value was not disclosed. The financing is Triad Digital Media’s first institutional investment.

Care Dynamix, a provider of nationwide preventative health services like in-school vaccination programs, has raised $7 million from H.I.G. Ventures.

Who says that venture capitalists have soured on Web 2.0 companies? Not Nathanial McNamara, who just left his H.I.G. Ventures to form Yasnap, a company that leverages Facebook Connect to help users create social media applications.

McNamara isn’t talking much about the new venture yet, except to say that it plans to launch in early 2009. Its beta is currently accessible, however, and includes such user-generated apps as: Pass a green beer, kick the can and pass the hot potato.